Saturday 17 October 2026 Export ANIK’s income statement to Excel — free account

Anika Therapeutics Inc.

ANIK Healthcare Drug Manufacturers Specialty & Generic

Anika Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $112.8 million, down 5.91% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 189.3% and free cash flow grew 61.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.98 0.71 −3.43%

Follow ANIK

Alert me

Market cap: $276.9M
P/E: 0.0×
Fwd P/E: −20.0×
Dividend yield: —
F-score: 6/9
Altman Z: 3.13
Beneish M: −2.84
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	6	6	7
ROE Full definition →		(20.23%)	(7.32%)	(7.84%)	(2.66%)
ROA Full definition →		(15.70%)	(5.54%)	(5.98%)	(2.04%)
ROIC Full definition →		(8.73%)	(8.03%)	(8.25%)	(3.24%)
Return on Tangible Assets Full definition →		(26.82%)	(8.93%)	(9.85%)	(3.23%)
Average Days of Receivables Full definition →		71.79	76.64	80.90	87.92
Free Cash Flow per Share Full definition →		0.09	0.35	(0.21)	0.04
Free Cash Flow Full definition →		1.25	4.96	(2.86)	0.56
Capital Expenditures Full definition →		(6.88)	(6.23)	(9.33)	(5.41)
Other line items
Cash ROIC Full definition →		0.61%	2.47%	(1.63%)	0.32%
Accounts Receivable Turnover Full definition →		4.46	4.77	4.87	4.55
Accounts Payable Turnover Full definition →		8.85	8.41	8.29	8.29
Inventory Turnover Full definition →		1.83	2.30	2.18	2.01
Average Days of Payables Full definition →		33.83	44.99	48.06	49.86
Days of Inventory on Hand Full definition →		116.42	139.91	173.16	228.39
Tax Rate Full definition →		0.42	0.07	0.08	0.07
Research and Development Expense of Revenue Full definition →		22.89%	22.84%	22.73%	22.75%
Selling, General and Administrative Expense of Revenue Full definition →		42.84%	43.51%	46.41%	43.66%
Share Based Compensation of Revenue Full definition →		8.76%	8.94%	11.92%	10.90%
Operating CF/Net income Full definition →		(0.25)	(1.03)	(0.58)	(1.58)
Depreciation/Fixed assets Full definition →		0.14	0.14	0.14	0.14
Capex/Depreciation Full definition →		(1.23)	(1.09)	(1.68)	(0.96)
Revenue per Share Full definition →		7.82	7.87	8.59	9.05
Operating CF per Share Full definition →		0.56	0.78	0.48	0.45
Capex per Share Full definition →		(0.48)	(0.43)	(0.69)	(0.41)
Capex to Sales Full definition →		0.06	0.06	0.08	0.04

Show all line items

Columns are period end dates

Stockrow Weekly